Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Wizz Air passenger numbers grow 11.4pc in August

(Sharecast News) - Low-cost carrier Wizz Air said on Tuesday that it had carried 6.91m passengers during August, an 11.4% increase year-on-year. Wizz Air also said seat capacity increased 12.1% year-on-year, with a "resilient" load factor of 94.8%, down only -0.60 percentage points on last year's load factor of 95.4%, demonstrating "continued strong demand".

On the operational front, the London-listed group stated that while the last originating service from its to-be-closed Abu Dhabi base flew on 31 August, Wizz said it was now continuing to rebuild its Tel Aviv station following the Summer suspension, with a full service of 24 routes to be deployed by mid-September.

Wizz Air also announced a strategic distribution partnership with flight content aggregator Travelfusion during August, which it said will help it better reach the 45% of travellers in Europe who still prefer to book through a retail channel, positioning it for "incremental revenue growth and expanded market reach".

As of 0925 BST, Wizz shares were down 2.67% at 1,313.52p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.